The startup develops a cardiovascular diagnostic device that records real-time cardiac impulses in out-of-hospital settings, enabling healthcare providers to monitor and manage heart disease effectively. This technology enhances the detection and prevention of cardiac conditions, improving patient outcomes through timely diagnosis and treatment.
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cardiovascular diseases (CVDs) are a leading cause of death globally, often requiring timely diagnosis and continuous monitoring to improve patient outcomes. Traditional ECG systems can be bulky and not easily accessible in out-of-hospital settings, limiting the ability to promptly detect and manage cardiac conditions.
Solution
iMedrix offers KardioScreen™, a mobile and cloud-connected ECG solution that enables healthcare providers to monitor and manage heart conditions efficiently, regardless of location. This FDA-cleared, medical-grade device provides 12/6 lead ECG capabilities, allowing doctors to respond quickly to diagnose and manage underlying conditions from the bedside or remotely. The system's real-time data transmission and analysis capabilities facilitate early detection of heart disease and timely intervention, improving patient care and reducing the costs associated with CVD management.
Target Audience
The primary target audience includes hospitals and health systems, primary care and specialist clinics, senior care facilities, home healthcare providers, EMS services, insurance companies, pharmaceutical companies, and individual patients at high risk of cardiac events.
Features
- Mobile, pocket-sized device for easy portability and use in various settings
- FDA 510(k) cleared medical-grade 12/6 lead ECG solution
- Cloud connectivity for real-time data access and remote monitoring
- AI and ML-driven CVD risk stratification
- Seamless integration with existing EMR systems
- Low cost per ECG (less than $0.50)
- Optional 24/7 ECG reading service
- Compatible with traditional ECG adhesive electrode patches